Naphazoline HCl 0.025 % / pheniramine maleate 0.3 % Ophthalmic Solution
RxNorm 1043658
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1043658 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: naphazoline HCl 0.025 % / pheniramine maleate 0.3 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Naphazoline hydrochloride 0.25 mg/ML / pheniramine maleate 3 mg/ML Ophthalmic Solution
(Atom ID: 12344727)
PSNPrescribable
Prescribable Name (PSN):
Naphazoline HCl 0.025 % / pheniramine maleate 0.3 % Ophthalmic Solution
(Atom ID: 6401857)
SYPrescribable
Synonym (SY):
Naphazoline hydrochloride 0.025 % / pheniramine maleate 0.3 % Ophthalmic Solution
(Atom ID: 3804283)
PTPrescribable
Designated preferred name (PT):
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
(Atom ID: 11437728)
FNPrescribable